Expert opinion on fecal microbiota transplantation for the treatment of Clostridioides difficile infection and beyond

References

• Zhang D, Prabhu VS, Marcella SW. Attributable healthcare resource utilization and cost for patients with primary and recurrent Clostridium difficile infection in the United States. Clin Infect Dis. 2018 Apr 17;66(9):1326–1332. PubMed PMID: 29360950; PubMed Central PMCID: PMC5905590.
   PubMed Web of Science ®Google Scholar
• Edelstein CA, Kassam Z, Jamie D, et al. The regulation of fecal microbiota for transplantation: an iternational perspect for policy and public health. Clin Res Regul Aff. 2015;32(3):99–107.
   Google Scholar
• Alyssa L, Byron P. Clostridium difficile infection and fecal microbiota transplant. AACN Adv Crit Care. 2016;27(3):324–337.
   PubMed Web of Science ®Google Scholar
• Hota SS, Poutanen SM. Is a single fecal microbiota transplant a promising treatment for recurrent Clostridium difficile infection? Open Forum Infect Dis. 2018 Feb 23;5(3):ofy045. eCollection 2018 Mar. PubMed PMID: 29600252; PubMed Central PMCID: PMC5868186.
   PubMed Web of Science ®Google Scholar
• Ohshima T, Osaki T, Yamamoto Y, et al. Evaluation of risk factors for Clostridium difficile infection based on immunochromatography testing and toxigenic culture assay. J Clin Microbiol. 2018 Nov 27;56(12):pii: e00555-18. Print 2018 Dec. PubMed PMID: 30232129; PubMed Central PMCID: PMC6258861.
   PubMed Web of Science ®Google Scholar
• Kelly CR, de Leon L, Jasutkar N. Fecal microbiota transplantation for relapsing Clostridium difficile infection in 26 patients: methodology and results. J Clin Gastroenterol. 2012 Feb;46(2):145–149.
   PubMed Web of Science ®Google Scholar
• Ma GK, Brensinger CM, Wu Q, et al. Increasing incidence of multiply recurrent Clostridium difficile infection in the United States: A cohort study. Ann Intern Med. 2017 Aug 1;167(3):152–158.
   PubMed Web of Science ®Google Scholar
• Varier RU. Cost‐effectiveness analysis of fecal microbiota transplantation for recurrent Clostridium difficile infection. Infect Control Hosp Epidemiol. 2015;36:438–444.
   PubMed Web of Science ®Google Scholar
• Bakken JS, Polgreen PM, Beekmann SE, et al. Treatment approaches including fecal microbiota transplantation for recurrent Clostridium difficile infection (RCDI) among infectious disease physicians. Anaerobe. 2013;24:20–24.
   PubMed Web of Science ®Google Scholar
• Van Nood E, Vrieze A, Nieuwdorp M, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med. 2013 Jan 31;368(5):407–415.
   PubMed Web of Science ®Google Scholar
• Cammarota G, Masucci L, Ianiro G, et al. Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. Aliment Pharmacol Ther. 2015 May;41(9):835–843.
   PubMed Web of Science ®Google Scholar
• Kelly CR, Khoruts A, Staley C, et al. Effect of fecal microbiota transplantation on recurrence in multiply recurrent Clostridium difficile infection: A randomized trial. Ann Intern Med. 2016 Nov 1;165(9):609–616.
   PubMed Web of Science ®Google Scholar
• Mamo Y, Woodworth MH, Wang T, et al. Durability and long-termclinical outcomes of fecal microbiota transplant treatment in patients with recurrent Clostridium difficile infection. Clin Infect Dis. 2018 May 17;66(11):1705–1711.
   PubMed Web of Science ®Google Scholar
• Eiseman B, Silen W, Bascom GS, et al. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery. 1958 Nov;44(5):854–859.
   PubMed Web of Science ®Google Scholar
• Borody TJ, Khoruts A. Fecal microbiota transplantation and emerging applications. Nat Rev Gastroenterol Hepatol. 2011;9:88–96.
   PubMed Web of Science ®Google Scholar
• Kassam Z, Lee CH, Hunt RH. Review of the emerging treatment of Clostridium difficile infection with fecal microbiota transplantation and insights into future challenges. Clin Lab Med. 2014 Dec;34(4):787–798.
   PubMed Web of Science ®Google Scholar
• McDonald LC, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis. 2018;66:e1.
   PubMed Web of Science ®Google Scholar
• Allegretti JR, Kassam Z, Osman M, et al. The 5D framework: a clinical primer for fecal microbiota transplantation to treat Clostridium difficile infection. Gastrointest Endosc. 2018 Jan;87(1):18–29.
   PubMed Web of Science ®Google Scholar
• Debast SB, Bauer MP, Kuijper EJ. European society of clinical microbiology and infectious diseases: update of the treatment guidance document for Clostridium difficile infection. Clin Microbiol Infect. 2014;20:1–26.
   PubMed Web of Science ®Google Scholar
• Fischer M, Sipe B, Cheng YW, et al. Fecal microbiota transplant in severe and severe-complicated Clostridium difficile: a promising treatment approach. Gut Microbes. 2017;8:289–302.
   PubMed Web of Science ®Google Scholar
• Tixier EN, Verheyen E, Ungaro RC, et al. Faecal microbiota transplant decreases mortality in severe and fulminant Clostridioides difficile infection in critically ill patients. Aliment Pharmacol Ther. 2019 Oct 14. DOI:10.1111/apt.15526. [Epub ahead of print] PubMed PMID: 31612528.
   Web of Science ®Google Scholar
• Hocquart M, Lagier JC, Cassir N, et al. Early fecal microbiota transplantation improves survival in severe Clostridium difficile infections. Clin Infect Dis. 2018 Feb 10;66(5):645–650. PubMed PMID: 29020328.
   PubMed Web of Science ®Google Scholar
• Quraishi MN, Widlak M, Bhala N, et al. Systematic review with meta-analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection. Aliment Pharmacol Ther. 2017;46:479–493.
   PubMed Web of Science ®Google Scholar
• Seder CW, Villalba MR Jr., Robbins J, et al. Early colectomy may be associated with improved survival in fulminant Clostridium difficile colitis: an 8-year experience. Am J Surg. 2009;197:302–307. PMID:19245905
   PubMed Web of Science ®Google Scholar
• Bhangu A, Nepogodiev D, Gupta A, et al., West Midlands Research C Systematic review and meta- analysis of outcomes following emergency surgery for Clostridium difficile colitis. Br J Surg. 2012;99:1501–1513. PMID:22972525
   PubMed Web of Science ®Google Scholar
• Stewart DB, CS H, MZ W. Is colectomy for fulminant Clostridium difficile colitis life saving? A systematic review. Colorectal Dis. 2013;15:798–804. PMID:23350898
   PubMed Web of Science ®Google Scholar
• Vindigni SM, Surawicz CM. Fecal microbiota transplantation. Gastroenterol Clin North Am. 2017;46:171–185.
   PubMed Web of Science ®Google Scholar
• Million M, Hocquart M, Seghboyan JM, et al. Faecal microbiota transplantation as salvage therapy for fulminant Clostridium difficile infections. Int J Antimicrob Agents. 2015 Aug;46(2):227–228. Epub 2015 Jun 3. PubMed PMID: 26092095
   PubMed Web of Science ®Google Scholar
• Alukal J, Dutta SK, Surapaneni BK, et al. Safety and efficacy of fecal microbiota transplant in 9 critically ill patients with severe and complicated Clostridium difficile infection with impending colectomy. J Dig Dis. 2019 Jun;20(6):301–307. Epub 2019 May 10. PubMed PMID: 30969003
   PubMed Web of Science ®Google Scholar
• Cammarota G, Ianiro G, Magalini S, et al. Decrease in surgeryfor Clostridium difficile infection after starting a program to transplant FecalMicrobiota. Ann Intern Med. 2015 Sep 15;163(6):487–488. PubMed PMID: 26370022.
   PubMed Web of Science ®Google Scholar
• Kelly CR, Ihunnah C, Fischer M, et al. Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients. Am J Gastroenterol. 2014;109(7):1065–1071.
   PubMed Web of Science ®Google Scholar
• Cheng YW, Phelps E, Ganapini V, et al. Fecal microbiota transplantation for the treatment of recurrent and severe Clostridium difficile infection in solid organ transplant recipients: A multicenter experience. Am J Transplant. 2018 Aug 7;19(2):501–511.
   Web of Science ®Google Scholar
• Bajaj JS, Kakiyama G, Savidge T, et al. Antibiotic-associated disruption of microbiota composition and function in cirrhosis is restored by fecal transplant. Hepatology. 2018 Oct;68(4):1549–1558.
   PubMed Web of Science ®Google Scholar
• De Sire R, Talocco C, Petito V, et al. Microbiota and inflammatory bowel disease: an update. Recenti Prog Med. 2018 Dec;109(12):570–573.
   PubMedGoogle Scholar
• Cozar‐Llisto A, Ramos‐Martinez A, Cobo J. Clostridium difficile infection in special high‐risk populations. Infect Dis Ther. 2016;5:253‐269.
   PubMed Web of Science ®Google Scholar
• Cheng YW, Phelps E, Ganapini V, et al. Fecal microbiota transplantation for the treatment of recurrent and severe Clostridium difficile infection in solid organ transplant recipients: A multicenter experience. Am J Transplant. 2019 Feb;19(2):501–511. Epub] 2018 Aug 31. PubMed PMID: 30085388; PubMed Central PMCID: PMC6349556]
   PubMed Web of Science ®Google Scholar
• Woodworth MH, Kraft CS, Meredith EJ, et al. Tacrolimus concentration to dose ratio in solid organ transplant patients treated with fecal microbiota transplantation for recurrent Clostridium difficile infection. Transpl Infect Dis. 2018 Apr;20(2):e12857. Epub 2018 Mar 13. PubMed PMID: 29446866; PubMed Central PMCID: PMC5891373
   PubMed Web of Science ®Google Scholar
• Fischer M. Recent research on fecal microbiota transplantation in inflammatory bowel disease patients. Gastroenterol Hepatol. 2019 Jan;15(1):44–47. PubMed PMID: 30899209; PubMed Central PMCID: PMC6423689
   Google Scholar
• Imdad A, Nicholson MR, Tanner-Smith EE, et al. Fecal transplantation for treatment of inflammatory bowel disease. Cochrane Database Syst Rev. 2018 Nov 13;11:CD012774. PubMed PMID: 30480772; PubMed Central PMCID:PMC65172.
   PubMedGoogle Scholar
• Kellermayer R. Fecal microbiota transplantation: great potential with many challenges. Transl Gastroenterol Hepatol. 2019;4:40. eCollection 2019. Review. PubMed PMID: 31231707; PubMed Central PMCID: PMC6556677
   PubMed Web of Science ®Google Scholar
• Newman KM, Rank KM, Vaughn BP, et al. Treatment of recurrent Clostridium difficile infection using fecal microbiota transplantation in patients with inflammatory bowel disease. Gut Microbes. 2017;8(3):303–309.
   PubMed Web of Science ®Google Scholar
• Costello SP, Hughes PA, Waters O, et al. Effect of fecal microbiota transplantation on 8-week remission in patients with ulcerative colitis: a randomized clinical trial. JAMA. 2019 Jan 15;321(2):156–164. PubMed PMID: 30644982; PubMed Central PMCID: PMC6439766.
   PubMed Web of Science ®Google Scholar
• Ianiro G, Eusebi LH, Black CJ, et al. Systematic review with meta-analysis: efficacy of faecal microbiota transplantation for the treatment of irritable bowel syndrome. Aliment Pharmacol Ther. 2019 Aug;50(3):240–248. Epub 2019 May 28. Review. PubMed PMID: 31136009
   PubMed Web of Science ®Google Scholar
• Shaukat A, Brenner DM. Fecal microbiota transplant for irritable bowel syndrome: panacea or placebo? Am J Gastroenterol. 2019 Jul;114(7):1032–1033. PubMed PMID: 31082878
   PubMed Web of Science ®Google Scholar
• Halkjær SI, Christensen AH, Lo BZS, et al. Faecal microbiota transplantation alters gut microbiota in patients with irritable bowel syndrome: results from a randomised, double-blind placebo-controlled study. Gut. 2018;67:2107–2115.
   PubMed Web of Science ®Google Scholar
• Kim KO, Gluck M. Fecal microbiota transplantation: an update on clinical practice. Clin Endosc. 2019 Mar;52(2):137–143. Epub 2019 Mar 26. PubMed PMID: 30909689; PubMed Central PMCID: PMC6453848
   PubMed Web of Science ®Google Scholar
• Crobach MJ, Planche T, Eckert C, et al. European society of clinical microbiology and infectious diseases: update of the diagnostic guidance document for Clostridium difficile infection. Clin Microbiol Infect. 2016;22(Suppl 4):S63–81.
   PubMed Web of Science ®Google Scholar
• Mullish BH, Quraishi MN, Segal JP, et al. The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines. J Hosp Infect. 2018 Sep;100(Suppl 1):S1–S31. PubMed PMID: 30173851
   PubMedGoogle Scholar
• Fischer M, Kao D, Mehta SR, et al. Predictors of early failure after fecal microbiota transplantation for the therapy of Clostridium difficile infection: A multicenter study. Am J Gastroenterol. 2016 Jul;111(7):1024–1031.
   PubMed Web of Science ®Google Scholar
• Bakken JS, Borody T, Brandt J, et al. Treating Clostridium difficile infection with fecal microbiota transplantation. Clin Gastroenterol Hepatol. 2011 Dec;9(12):1044–1104.
   PubMed Web of Science ®Google Scholar
• Bakken JS, Borody T, Brandt LJ, et al. Fecal microbiota transplantation workgroup. Treating Clostridium difficile infection with fecal microbiota transplantation. Clin Gastroenterol Hepatol. 2011 Dec;9(12):1044–1049. Epub 2011 Aug 24. Review. PubMed PMID: 21871249; PubMed Central PMCID: PMC3223289
   PubMed Web of Science ®Google Scholar
• Cammarota G, Ianiro G, Tilg H, et al. European FMT Working Group. European consensus conference on faecal microbiota transplantation in clinical practice. Gut. 2017 Apr;66(4):569–580. Epub 2017 Jan 13. PubMed PMID: 28087657; PubMed Central PMCID: PMC5529972
   PubMed Web of Science ®Google Scholar
• Sokol H, Galperine T, Kapel N, et al. French group of Faecal microbiota Transplantation (FGFT). Faecal microbiota transplantation in recurrent Clostridium difficile infection: recommendations from the French Group of Faecal microbiota Transplantation. Dig Liver Dis. 2016 Mar;48(3):242–247. Epub 2015 Sep 7. PubMed PMID: 26433619
   PubMedGoogle Scholar
• Krajicek E, Fischer M, Allegretti JR, et al. Nuts and bolts of fecal microbiota transplantation. Clin Gastroenterol Hepatol. 2019 Jan;17(2):345–352.
   PubMed Web of Science ®Google Scholar
• Hamilton MJ, Weingarden AR, Sadowsky MJ, et al. Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection. Am J Gastroenterol. 2012;107:pp. 761–767.
   PubMed Web of Science ®Google Scholar
• Youngster I, Mahabamunuge J, Systrom HK, et al. Oral, frozen fecal microbiota transplant (FMT) capsules for recurrent Clostridium difficile infection. BMC Med. 2016 Sep 9;14(1):134,016-0680-9.
   PubMedGoogle Scholar
• Smith M, Kassam Z, Edelstein C, et al. OpenBiome remains open to serve the medical community. Nat Biotechnol. 2014;32:867.
   PubMed Web of Science ®Google Scholar
• Kazerouni A, Burgess J, Burns LJ, et al. Optimal screening and donor management in a public stool bank. Microbiome. 2015;3:75.
   PubMed Web of Science ®Google Scholar
• Edelstein C, Daw JR, Kassam Z. Seeking safe stool: canada needs a universal donor model. CMAJ. 2016;188(17–18):E431–E432.
   PubMed Web of Science ®Google Scholar
• Youngster I, Sauk J, Pindar C, et al. Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: a randomized, open label, controlled pilot study. Clin Infect Dis. 2014;58:1515.
   PubMed Web of Science ®Google Scholar
• Kim KO, Schwartz M, Gluck M. Reducing cost and scheduling complexity of fecal microbiota transplantation by using universal donor over patients-directed donors in patients with recurrent Clostrodium difficile infections. Gastroenterology. 2018;154(6 Suppl 1):S191.
   Web of Science ®Google Scholar
• Paramsothy S, Kamm MA, Kaakoush NO, et al. Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomized placebo-controlled trial. Lancet. 2017 Mar 25;389(10075):1218–1228. Epub 2017 Feb 15. PubMed PMID: 28214091
   PubMed Web of Science ®Google Scholar
• McSweeney B, Allegretti JR, Fischer M, et al. In search of stool donors: a multicenter study of prior knowledge, perceptions, motivators, and deterrents among potential donors for fecal microbiota transplantation. Gut Microbes. 2019 May;23:1–12.
   Google Scholar
• Ramai D, Zakhia K, Ofosu A, et al. Fecal microbiota transplantation: donor relation, fresh or frozen, delivery methods, cost-effectiveness. Ann Gastroenterol. 2019 Jan-Feb;32(1):30–38. Epub 2018 Nov 17. Review. PubMed PMID: 30598589; PubMed Central PMCID: PMC6302197.
   PubMed Web of Science ®Google Scholar
• Kassam Z, Lee CH, Yuan Y, et al. Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis. Am J Gastroenterol. 2013;108:500–508.
   PubMed Web of Science ®Google Scholar
• Lawrence JB, Olga CA. An overview of fecal microbiota transplantation: techniques, indications, and outcomes. Gastrointest Endosc. 2013 Aug 01;78(2):240–249.
   PubMed Web of Science ®Google Scholar
• Atreja A, Rizk MK. Fecal microbiota transplantation for recurrent C difficile infection: ready for prime time? Clev Clin J Med. 2013 Feb;80(2):101–108.
   PubMed Web of Science ®Google Scholar
• Woodworth MH, Carpentieri C, Sitchenko KL, et al. Challenges in fecal donor selection and screening for fecal microbiota transplantation: a review. Gut Microbes. 2017;8:225–237.
   PubMed Web of Science ®Google Scholar
• Cammarota G, Ianiro G, Kelly CR, et al. International consensus conference on stool banking for faecal microbiota transplantation in clinical practice. Gut. 2019 Sep 28:pii: gutjnl-2019-319548. DOI:10.1136/gutjnl-2019-319548. [Epub ahead of print] PubMed PMID: 31563878.
   PubMed Web of Science ®Google Scholar
• Youngster I, Russell GH, Pindar C, et al. Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection. JAMA. 2014 Nov 5;312(17):1772–1778.
   PubMed Web of Science ®Google Scholar
• Kao D, Roach B, Silva M, et al. Effect of oral capsule- vs colonoscopy delivered fecal microbiota transplantation on recurrent Clostridium difficile infection: a randomized clinical trial. JAMA. 2017;318:1985–1993.
   PubMed Web of Science ®Google Scholar
• Ianiro G, Maida M, Burisch J, et al. Efficacy of different faecal microbiota transplantation protocols for Clostridium difficile infection: A systematic review and meta-analysis. United European Gastroenterol J. 2018 Oct;6(8):1232–1244. Epub 2018 Jun 3. PubMed PMID: 30288286; PubMed Central PMCID: PMC6169051
   PubMed Web of Science ®Google Scholar
• Brandt LJ, Borody TJ, Campbell J. Endoscopic fecal microbiota transplantation: “first-line” treatment for severe Clostridium difficile infection? J Clin Gastroenterol. 2011;45:655–657.
   PubMed Web of Science ®Google Scholar
• Yoon SS, Brandt LJ. Treatment of refractory/recurrent C. difficile-associated disease by donated stool transplanted via colonoscopy: a case series of 12 patients. J Clin Gastroenterol. 2010 Sep;44(8):562–566.
   PubMed Web of Science ®Google Scholar
• Luo Y, Lucas AL, Grinspan AM. Fecal transplants by colonoscopy and capsules are cost-effective strategies for treating recurrent Clostridioides difficile infection. Dig Dis Sci. 2019 Sep 6. DOI:10.1007/s10620-019-05821-1. [Epub ahead of print] PubMed PMID: 31493042.
   Google Scholar
• Lee CH, Belanger JE, Kassam Z, et al. The outcome and long-term follow-up of 94 patients with recurrent and refractory Clostridium difficile infection using single to multiple fecal microbiota transplantation via retention enema. Eur J Clin Microbiol Infect Dis. 2014 Aug;33(8):1425–1428.
   PubMed Web of Science ®Google Scholar
• Lee CH, Steiner T, Petrof EO, et al. Frozen vs fresh fecal microbiota transplantation and clinical resolution of diarrhea in patients with recurrent Clostridium difficile infection: A randomized clinical trial. JAMA. 2016 Jan 12;315(2):142–149.
   PubMed Web of Science ®Google Scholar
• Brandt LJ, Aroniadis OC. An overview of fecal microbiota transplantation: techniques, indications, and outcomes. Gastrointest Endosc. 2013 Aug;78(2):240–249.
   PubMed Web of Science ®Google Scholar
• Kelly CR, Ihunnah C, Fischer M, et al. Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients. Am J Gastroenterol. 2014 Jul;109(7):1065–1071.
   PubMed Web of Science ®Google Scholar
• Cohen NA, Livovsky DM, Yaakobovitch S, et al. Comparison of fecal microbial transplantation methods for recurrent Clostridium difficile infection. Isr Med Assoc J. 2016 Oct;18(10):594–599.
   PubMed Web of Science ®Google Scholar
• Moayyedi P, Yuan Y, Baharith H, et al. Faecal microbiota transplantation for Clostridium difficile-associated diarrhoea: a systematic review of randomized controlled trials. Med J Aust. 2017;207:166–172.
   PubMed Web of Science ®Google Scholar
• Lee CH, Steiner T, Petrof EO, et al. Frozen vs fresh fecal microbiota transplantation and clinical resolution of diarrhea in patients with recurrent Clostridium difficile infection: a randomized clinical trial. JAMA. 2016;315:142–149.
   PubMed Web of Science ®Google Scholar
• Ianiro G, Masucci L, Quaranta G, et al. Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection-single versus multiple infusions. Aliment Pharmacol Ther. 2018 Jul;48(2):152–159. Epub 2018 May 30. PubMed PMID: 29851107
   PubMed Web of Science ®Google Scholar
• Tang G, Yin W, Liu W. Is frozen fecal microbiota transplantation as effective as fresh fecal microbiota transplantation in patients with recurrent or refractory Clostridium difficile infection: a meta-analysis? Diagn Microbiol Infect Dis. 2017;88:322–329.
   PubMed Web of Science ®Google Scholar
• Camacho-Ortiz A, Gutiérrez-Delgado EM, Garcia-Mazcorro JF, et al. Randomized clinical trial to evaluate the effect of fecal microbiota transplant for initial Clostridium difficile infection in intestinal microbiome. PLoS One. 2017 Dec 20;12(12):e0189768.
   PubMed Web of Science ®Google Scholar
• Gough E, Shaikh H, Manges AR. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis. 2011;53:994–1002.
   PubMed Web of Science ®Google Scholar
• Costello SP, Conlon MA, Vuaran MS, et al. Faecal microbiota transplant for recurrent Clostridium difficile infection using long-term frozen stool is effective:clinical efficacy and bacterial viability data. Aliment Pharmacol Ther. 2015;42:1011–1018.
   PubMed Web of Science ®Google Scholar
• Costello SP, Tucker EC, La Brooy J, et al. Establishing a fecal microbiota transplant service for the treatment of Clostridium difficile infection. Clin Infect Dis. 2016;62(7):908–914.
   PubMed Web of Science ®Google Scholar
• Allegretti JR, Allegretti AS, Phelps E, et al. Classifying fecal microbiota transplantation failure: an observational study examining timing and characteristics of fecal microbiota transplantation failures. Clin Gastroenterol Hepatol. 2017;16(11):1832–1833. PubMed PMID: 29104129.
   Web of Science ®Google Scholar
• Allegretti JR, Kao D, Sitko J, et al. Early antibiotic use after fecal microbiota transplantation increases risk of treatment failure. Clin Infect Dis. 2018 Jan 6;66(1):134–135. PubMed PMID: 29020157.
   PubMed Web of Science ®Google Scholar
• Allegretti JR, Kao D, Phelps E, et al. Risk of Clostridium difficile infection with systemic antimicrobial therapy following successful fecal microbiota transplant: should we recommend anti-Clostridium difficile antibiotic prophylaxis? Dig Dis Sci. 2019 Jan 10. DOI:10.1007/s10620-018-5450-4. [Epub ahead of print] PubMed PMID: 30632052.
   Web of Science ®Google Scholar
• Tariq R, Pardi DS, Khanna S. Sa1847—predictors of failure after fecal micro-biota transplantation for recurrent C. difficile infection: a systematic review and meta-analysis. Gastroenterology. 2018;154:S–418.
   Web of Science ®Google Scholar
• Ianiro G, Valerio L, Masucci L, et al. Predictors of failure after single faecal microbiota transplantation in patients with recurrent Clostridium difficile infection: results from a 3-year, single-centre cohort study. Clin Microbiol Infect. 2017;23(5):337 e1–337 e3.
   Web of Science ®Google Scholar
• Van Hise NW, Bryant AM, Hennessey EK, et al. Efficacy of oral vancomycin in preventing recurrent Clostridium difficile infection in patients treated with systemic antimicrobial agents. Clin Infect Dis. 2016;63(5):651–653.
   PubMed Web of Science ®Google Scholar
• Allegretti JR, Kearney S, Li N, et al. Recurrent Clostridium difficile infection associates with distinct bile acid and microbiome profiles. Aliment Pharmacol Ther. 2016 Jun;43(11):1142–1153.
   PubMed Web of Science ®Google Scholar
• Khoruts A, Sadowsky MJ. Understanding the mechanisms of faecal microbiota transplantation. Nat Rev Gastroenterol Hepatol. 2016 Sep;13(9):508–516.
   PubMed Web of Science ®Google Scholar
• Baxter M, Ahmad T, Colville A, et al. Fatal aspiration pneumonia as a complication of fecal microbiota transplant. Clin Infect Dis. 2015 Jul 1;61(1):136–137.
   PubMed Web of Science ®Google Scholar
• Panchal P, Budree S, Scheeler A, et al. Correction to: scaling safe access to fecal microbiota transplantation: past, present, and future. Curr Gastroenterol Rep. 2018 Jun 8;20(7):28. PubMed PMID: 29884929.
   PubMedGoogle Scholar
• The Food and Drug Administration (FDA). Important safety alert regarding use of fecal microbiota for transplantation and risk of serious adverse reactions due to transmission of multi-drug resistant organisms [Internet]. Silver Spring (MD): US Food amd Drug Administration. [updated 2019 Jun 13; cited 2019 Aug 27]. Available from: https://www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/important-safety-alert-regarding-use-fecal-microbiota-transplantation-and-risk-serious-adverse
   Google Scholar
• Wang S, Xu M, Wang W, et al. Systematic review: adverse events of fecal microbiota transplantation. PLoS One. 2016 Aug 16;11(8):e0161174.
   PubMed Web of Science ®Google Scholar
• Joseph J, Saha S, Greenberg-Worisek AJ. Fecal microbiota transplantation: an ambiguous translational pathway for a promising treatment. Clin Transl Sci. 2019 May;12(3):206–208. Epub 2019 Mar 12. PubMed PMID: 30861317; PubMed Central PMCID: PMC6510370)
   PubMed Web of Science ®Google Scholar
• U.S. food and drug administration. guidance for industry: enforcement policy regarding investigational new drug requirements for use of fecal microbiota for transplantation to treat Clostridium difficile infection not responsive to standard therapies. 2016. https://Www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/guidances/vaccines/UCM488223.pdf
   Google Scholar
• Petrof EO, Gloor GB, Vanner SJ, et al. Stool substitute transplant therapy for the eradication of Clostridium difficile infection: ‘rePOOPulating’ the gut. Microbiome. 2013;1:1–12.
   PubMed Web of Science ®Google Scholar